A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with invasive fungal disease (IFD) caused by Aspergillus species

PI: Lior Nesher. Funded: IQVIA

A Phase I/II, single-center, randomized double masked placebo controlled study to evaluate the safety and efficacy of treatment with AS101 1% oral solution in patients with Covid-19

PI: Victor Novack. Funded: FERAMDA

Pegylated Interferon Lambda for Treatment of COVID-19 infection- A Randomized Open Label Pilot Study

PI: Ohad Etzion. Funded: Eiger BioPharmaceuticals, Inc

Breathalyzer Based Detection of COVID-19 Using Terahertz Spectroscopy and Nano- Antennas Metamaterials Chip

PI: Lior Nesher

Corona vaccinations

PI: Victor Novack. Funded: Praxell

Validation of a Novice Smartphone-Based Ultrasound Device for the Detection of Lung Pathologies Conducted on COVID-19 Inpatients Admitted to Critical Care Unit and Internal Ward

PI: Offer. Funded: PulseNmore

Validate the Performance and Utility of PIT-M3D International’s Diagnostic by Retrospective Data

PI: Victor Novack